Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...

Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

Researchers have completed the first phase of a collaboration integrating robotic cell processing with automated ...

Cellares, an Integrated Development and Manufacturing Organization (IDMO), announced a $257 million Series D financing co‑led ...

Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...

The global stem cell manufacturing market size was valued at USD 15.83 billion in 2025 and is predicted to hit around USD ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...

- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions - In the pharmaceutical industry, the ...

Novo Nordisk has found a buyer for cell therapy technologies dropped in its retreat from the modality. Aspect Biosystems has ...